Geron (GERN -21%) adds to yesterday's AH decline following its announcement that it was...

|About: Geron Corporation (GERN)|By:, SA News Editor

Geron (GERN -21%) adds to yesterday's AH decline following its announcement that it was discontinuing the further development of its stem-cell programs and will eliminate 38% of its work force. The biopharmaceutical company plans to restructure its business to focus its resources on advancing its two cancer-drug candidates.